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Abstract: The present study assessed problems in Japanese prisoners (inmates) who abused 
methamphetamine.  Fifty-two  male  inmates  were  assessed  in  2005–2007  using  the 
Addiction Severity Index-Japanese version and compared with 55 male methamphetamine 
abusers  in  hospitals  and  recovery  centers.  The  
2  and  Mann-Whitney-Wilcoxon  tests 
showed that the inmates had a significantly lower education level, more frequently had  
full-time jobs, had more experience living with a sexual partner, and more frequently had a 
history of juvenile delinquency and criminal records than patients. Although psychiatric 
symptoms,  such  as  depression,  anxiety,  and  hallucinations,  were  not  common  among 
inmates, suicidal behavior and trouble controlling violence were common in both groups. 
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1. Introduction 
 
The production, trafficking, and use of amphetamine-type stimulants have increased significantly 
since the 1990s throughout East Asia and the Pacific countries [1]. The most prevalent amphetamine-type 
stimulant  in  East  Asia  is  methamphetamine,  the  principal  drug  involved  in  drug  abuse  cases  in  
Japan  [2,3].  Stimulant  dependence  presents  a  serious  problem,  not  only  for  patients,  but  also  for 
Japanese society [4]. For example, about 25% of convicted prisoners committed offenses under the 
Stimulant Control Law [5]. Although many Japanese methamphetamine abusers have received only 
punishment  rather  than  medical  treatment  [3],  drug-abuse  problems  in  inmates  have  not  been 
sufficiently investigated. Moreover, appropriate assessment and treatment of substance abuse have not 
been  provided  in  Japanese  prisons,  partly  because  the  number  of  inmates  in  Japan  exceeds  
prison capacity. 
In a study conducted at a Japanese hospital, methamphetamine abusers with serious criminal records 
tended to administer the drug by injection and had less chronic psychosis than those with less serious 
criminal records [6]. In a study of adolescents at a juvenile detention home, Miura et al. [7] reported 
that gender (female), age, number of admissions, violence, history of psychiatric treatment, and family 
history of drug misuse were significantly associated with methamphetamine use. Matsumoto et al. [8] 
reported  no  significant  correlation  between  drug  abuse  and  antisocial  behaviors  in  male  juvenile 
delinquents,  although  alcohol  abuse  has  been  hypothesized  to  promote  these  behaviors.  The 
aforementioned studies, however, did not include Japanese inmates under the Stimulant Control Law 
in their sample. Although Matsumoto et al. [9] found a relationship between childhood tendencies 
toward attention-deficit/hyperactivity disorder and illicit drug abuse in Japanese prisoners, they did not 
compare the characteristics of methamphetamine abusers in prison with those in treatment facilities. 
Investigation of methamphetamine abusers in correctional settings and comparison of the results with 
those in treatment settings would elucidate the specific characteristics of methamphetamine abusers in 
correctional settings. 
The Addiction Severity Index (ASI) [10] is used worldwide and is one of the few standardized 
instruments  that  address  drug  abuse.  The  ASI  assesses  legal  status  in  addition  to  medical  status, 
employment/support status, drug use status, alcohol use status, family/social status, and psychiatric 
status.  These  features  make  the  ASI  particularly  useful  for  practitioners  working  with  substance-
abusing offenders [11]. For example, some studies used the ASI with inmates to confirm their common 
characteristics [12], to compare inmates with other drug abusers [10], and to confirm the effectiveness 
of the ASI as a screening tool for substance use disorders [13]. The ASI was also used to examine 
associations between psychosocial and criminal factors [14], relationships between prescription drug 
abuse and addiction severity [15], gender differences in substance abuse disorders [16], the effectiveness 
of  methadone  maintenance  treatment  [17],  and  the  predictors  of  treatment  motivation  [18].  The  Int. J. Environ. Res. Public Health 2009, 6                 
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ASI-Japanese  version  (ASI-J)  has  acceptable  reliability  and  validity  for  Japanese  drug  abusers  in 
treatment settings [19]. 
Using the ASI-J, the present study assessed the characteristics and problems of Japanese inmates 
who abuse methamphetamine by comparing them with methamphetamine-abusing patients in treatment 
settings. Revealing such characteristics and problems may contribute to improving substance abuse 
treatment policy and improving the effectiveness of interventions designed to reduce stimulant abuse 
and its adverse consequences. 
 
2. Methods 
 
2.1. Recruitment Site 
 
The participants were recruited from an adult male-only prison in Shizuoka, Japan, from September 
2005  to  July  2006  and  in  February  2007.  In  this  prison,  offenders  mainly  came  from  Tokyo  or 
Shizuoka prefectures. In cases of repeat offenders, the inmates were detained in this prison for the first 
three months of their sentence. In October 2005, for example, 178 (164 Japanese and 14 foreigners) of 
the  1,407  total  inmates  were  imprisoned  for  methamphetamine  use  as  a  result  of  the  Stimulant  
Control Law. 
 
2.2. Participants and Procedure 
 
The study was approved by the Institutional Review Board of each facility. Sixty-three Japanese 
adult  (>20  years  old)  male  inmates  who  were  arrested  for  methamphetamine  use  based  on  the 
Stimulant Control Law were sequentially approached to participate in this study. They were recruited 
and interviewed within three months after their imprisonment. Of the 63 inmates, five (7.9%) refused 
to participate, and the remaining 58 (92.1%) were administered the Structured Clinical Interview of the 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) [20], Substance Abuse 
Disorders module. After the interview, five (7.9%) inmates were excluded from the study because they 
were not diagnosed with substance abuse or dependence. Written informed consent was obtained from 
the remaining 53 (84.0%) inmates. No inmates presented with acute psychosis. 
The ASI-J was administered to the 53 inmates to assess their characteristics and the severity of 
their problems. They were asked about their status before they had been arrested by the police. One 
inmate was excluded because of a pathologically disorganized response. Thus, data from 52 (82.5%) 
inmates were included in the statistical analysis. 
One psychiatrist and two clinical psychologists recruited participants and interviewed them. To 
achieve inter-rater reliability, two interviewers received six sessions of training interviews with another 
expert  interviewer  to  confirm  rating  consensus  between  all  interviewers.  Each  interview  for  each 
participant took approximately 60 min to complete. 
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2.3. Comparison with Participants in Treatment Settings: Recruitment Criteria and Facilities 
 
The ASI-J was administered to 111 drug abusers in treatment settings to examine its reliability and 
validity [19]. These participants were recruited at three hospitals and two recovery facilities between 
January 2002 and September 2004. Of the 111 drug abusers, 55 were included in the present study 
using the following criteria: at least 18 years old, male Japanese with a history of methamphetamine 
abuse, diagnosed as a drug abuser or drug dependent based on DSM-IV criteria, and an inpatient or 
outpatient at  a Japanese mental  hospital or recovery center or a  person who was recovering from 
stimulant  abuse  and  working  in  a  recovery  center.  Patients  in  the  acute  phase  of  psychosis  
were excluded. 
The numbers of participants from each facility were 23 (six inpatients, 17 outpatients, 0 recovering) 
from  Tokyo  Metropolitan  Matsuzawa  Hospital  in  Tokyo,  10  (one  inpatient,  nine  outpatients,  0 
recovering) from the National Center of Neurology and Psychiatry Musashi Hospital in Kodaira, two 
(one  inpatient,  one  outpatient,  0  recovering)  from  Fukko-kai  Tarumi  Hospital  in  Kobe,  17  (eight 
inpatients, three outpatients, six recovering) from Self Support Services in Tokyo, and three (three 
inpatients, 0 outpatient, 0 recovering) from GAIA in Naha. Inpatients were asked about their status 
during  the  30  days  prior  to  their  admission  to  the  substance  treatment  facility.  Outpatients  and 
recovering patients were simply asked about their status during the 30 days prior to the ASI interview. 
 
2.4. Statistical Analysis 
 
Significant differences between two ASI datasets were examined using the 
2 test for categorical 
data and Mann-Whitney-Wilcoxon test for continuous data. We used the Mann-Whitney-Wilcoxon test 
because  ASI  data  include  many  nonparametric  variables  and  zero  values  [21].  The  associations 
between continuous variables were analyzed by Spearman’s rank correlation coefficient. All analyses 
were performed using SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, USA). 
 
3. Results 
 
3.1. Characteristics of Participants 
 
Table  1  shows  the  general  characteristics  of  the  two  groups  (i.e.,  inmates  and  patients).  No 
significant differences were found in age between the two groups. Inmates had significantly lower 
education levels than patients. The majority of inmates had been married and had held a full-time job 
during the past three years. Half of the inmates lived with a sexual partner. In contrast, less than half of 
the patients had ever married or had a full-time job. Only one-fifth of the patients had ever lived with a 
sexual  partner.  The  inmates  more  frequently  had  a  history  of  juvenile  delinquency  and  had  more 
criminal charges of illicit drug use that resulted in conviction than patients. Crimes other than illicit 
drug use were more common among inmates than patients. Inmates had less access to mental health 
service, were given less medication for psychological problems, and received less psychiatric or drug 
treatment than patients. 
 Int. J. Environ. Res. Public Health 2009, 6                 
 
 
3060 
3.2. Severity Score and Related Items 
 
As shown in Table 2, inmates had significantly higher composite scores (CSs) related to drug use 
and  legal  status  than  patients.  In  contrast,  they  had  significantly  lower  CSs  related  to 
employment/support  and  psychiatric  symptoms.  The  CSs  for  medical  status,  alcohol  use,  and 
family/social relationships did not differ between the two groups. Similar to the CSs, the interviewer 
severity  ratings  (ISRs)  of  the  inmates  were  significantly  higher  for  drug  use  and  legal  status  and 
significantly lower for employment/support than patients. No significant differences were found for the 
other ISR variables between the two groups. 
 
Table 1. Characteristics of participants in each group. 
 
  Inmates (n = 52)  Patients (n = 55)  p values 
Age, M (± SD, range)  38.0 (± 1.5, 25–75 )  35.9 (± 1.2, 22–60)  n.s. 
Years of education, M (± SD)  9.8 (± 1.7)  11.6 (± 2.3)  p < 0.001*** 
Never married, n (%)  9 (17.3%)  36 (65.5%)  p < 0.001*** 
Full-time employment past 3 years, n (%)  40 (76.9%)  24 (43.6%)  p < 0.001*** 
Lived with sexual partner past 3 years, n (%)  30 (57.7%)  12 (21.8%)  p < 0.001*** 
Lived with parent(s) past 3 years, n (%)  26 (50.0%)  24 (43.6%)  n.s. 
Charged with juvenile delinquency, n (%)  42 (80.8%)  35 (63.6%)  p = 0.049* 
Charges resulting in conviction (illicit drugs), M (± SD)  2.67 (± 1.7)  0.98 (± 1.3)  p < 0.001*** 
Charges resulting in conviction (other than illicit drugs), n (%)  30 (57.7%)  16 (29.1%)  p = 0.003** 
Chronic medical problems, n (%)  20 (38.5%)  19 (34.5%)  n.s. 
Medication for any psychological emotional problem, n (%)  16 (30.8%)  40 (72.7%)  p < 0.001*** 
History of psychiatric treatment, n (%)  10 (19.2%)  26 (47.3%)  p = 0.002** 
Any drug detoxification treatments, n (%)  3 (5.8%)  18 (32.7%)  p < 0.001*** 
Any drug abuse treatment programs, n (%)  7 (13.5%)  45 (81.8%)  p < 0.001*** 
Any alcohol treatment programs, n (%)  2 (3.8%)  7 (12.7%)  p = 0.098 
n, number of participants; M, mean; SD, standard deviation; n.s., not significant. 
Note: Mann-Whitney Wilcoxon test was used for the statistical comparison for Age and Years of 
education. The 
2 test was used for the other categories.  
*p < 0.05, **p < 0.01, ***p < 0.001. 
 
Table 2. ASI-J composite scores (CSs) and interviewer severity ratings (ISRs). 
 
ASI-J area   
Inmates (n = 52) 
Mean (SD) 
Patients (n = 55) 
Mean (SD) 
p values 
Medical status 
(CS)  0.06 (0.02)  0.10 (0.03)  n.s. 
(ISR)  1.04 (0.25)  0.64 (0.22)  n.s. 
Employment/support 
(CS)  0.45 (0.04)  0.65 (0.04)  p < 0.001** 
(ISR)  2.85 (0.43)  4.60 (0.40)  p = 0.002** Int. J. Environ. Res. Public Health 2009, 6                 
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Table 2. Cont. 
Alcohol use 
(CS)  0.18 (0.03)  0.11 (0.02)  n.s. 
(ISR)  2.13 (0.38)  1.16 (0.29)  p = 0.086 
Drug use 
(CS)  0.20 (0.03)  0.14 (0.02)  p = 0.033* 
(ISR)  6.56 (0.24)  4.51 (0.38)  p < 0.001*** 
Legal status 
(CS)  0.47 (0.02)  0.03 (0.01)  p < 0.001*** 
(ISR)  6.98 (0.13)  0.56 (0.21)  p < 0.001*** 
Family/social relationships 
(CS)  0.26 (0.03)  0.21 (0.03)  n.s. 
(ISR)  4.19 (0.46)  2.95 (0.30)  p = 0.055 
Psychiatric symptoms 
(CS)  0.15 (0.03)  0.24 (0.03)  p = 0.030* 
(ISR)  2.44 (0.44)  3.05 (0.41)  n.s. 
n.s., not significant. 
Note: The Mann-Whitney Wilcoxon test was used for the statistical comparison. 
*p < 0.05, **p < 0.01, ***p < 0.001. 
 
Table 3. ASI-J items answered differently by inmates and patients. 
 
ASI-J items  Inmates (n = 52)  Patients (n = 55)  p values 
Employment/support       
paid working days in the past 30 days, M (SD)  13.3 (11.95)  8.6 (11.80)  p < 0.05* 
received money (Yen) for working in the 30 days, M (SD)  204,370 
(248,437) 
116,000 
(226,830)  p < 0.001*** 
received money (Yen) for illegal activities in the 30 days, M 
(SD) 
111,440 
(426,470)  10,070 (67,285)  p < 0.01** 
received financial support, n (%)  17 (65.4)  34 (18.2)  p < 0.001*** 
someone depends on you for the majority of life, M (SD)  0.92 (1.82)  0.37 (1.26)  p < 0.05* 
Drug use       
days of methamphetamine use in the past 30 days, M (SD)  13.0 (12.28)  1.4 (5.72)  p < 0.001*** 
days of multidrug use in the past 30 days, M (SD)  3.6 (8.99)  1.1 (5.66)  p < 0.05* 
money (Yen) spent on drugs in the past 30 days, M (SD)  72,400 (76,508)  10,560 (32,238)  p < 0.001*** 
Legal status       
days of illegal activities for profit in the past 30 days, M 
(SD)  2.8 (8.25)  0.4 (2.69)  p < 0.05* 
experience of arrest for drug charges, M (SD)  2.67 (1.66)  0.98 (1.25)  p < 0.001*** 
experience of arrest for parole violations, M (SD)  0.44 (0.50)  0.05 (0.29)  p < 0.001*** 
experience of arrest for assault, M (SD)  0.48 (0.93)  0.04 (0.18)  p < 0.001*** 
Psychiatric symptoms       
experience of hallucinations in the past 30 days, n (%)  1 (1.9)  8 (14.5)  p < 0.001*** 
prescribed medication for psychological and emotional 
problems in the past 30 days, n (%)  10 (19.2)  32 (58.2)  p < 0.001*** 
Other status (no difference in CS)       
days of alcohol use in the past 30 days, M (%)  12.15 (13.01)  5.60 (10.01)  p < 0.001*** 
money (Yen) spent on alcohol in the past 30 days, M (SD)  34,120 (66,473)  14,180 (45,545)  p < 0.001*** 
experience of serious problems with sexual partner in the 
past 30 days, n (%)  17 (32.0)  8 (13.0)  p < 0.001*** Int. J. Environ. Res. Public Health 2009, 6                 
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experiences of serious problems with sexual partner in their 
lifetime, n (%)  41 (79.0)  30 (56.0)  p < 0.001*** 
days of serious problems with their family in the past 30 
days, M (%)  4.37 (9.29)  0.98 (2.87)  p < 0.001*** 
n, number of participants; M, mean; SD, standard deviation 
Note:  The  Mann-Whitney  Wilcoxon  test  was  used  for  the  statistical  comparison  with 
continuous values. The 
2 test was used for the other categories. 
*p < 0.05, **p < 0.01, ***p < 0.001 
 
Table 3 shows a list of the ASI-J items that inmates and patients answered differently. With regard 
to employment/support status, inmates had more paid work and received more money for work in the 
past 30 days than patients. Inmates also received more money from illegal activities than patients. 
Fewer  inmates  received  financial  support  compared  with  patients.  Inmates  had  more  people  who 
depended on them for the majority of food, shelter, etc., than patients. 
With regard to drug use, inmates reported significantly more days of “methamphetamine use in the 
past 30 days” and “multidrug use in the past 30 days” than patients. Inmates spent more money on 
drugs in the past 30 days than patients. No significant differences were found between the two groups 
in the drug-use CS items with the exception of these three items. 
With regard to legal status, inmates more frequently engaged in illegal activities for profit in the 
past 30 days than patients. Inmates were arrested more frequently for drug charges, parole violations, 
and assault than patients. 
With regard to psychiatric symptoms, inmates experienced fewer hallucinations and were prescribed 
less medication for psychological and emotional problems in the past 30 days than patients. 
With regard to medical status, alcohol drinking status, and family/social relationships, no overall 
significant differences in CS were found between the two groups. However, significant differences 
were found in some of the items. For example, inmates reported significantly more days of alcohol use 
and spent more money on alcohol in the past 30 days than patients. Inmates also more frequently 
experienced  serious  conflicts  with  their  family  in  the  past  30  days  than  patients.  Similarly,  more 
inmates experienced serious problems with their sexual partner in the past 30 days and during their 
lifetime than patients. 
 
3.3. Substance Use Behavior 
 
Table 4 shows the number and percentage of participants who reported substance use/abuse lasting 
more than 1 year in their lifetime and who abused methamphetamine by injection. Table 4 also shows 
the average duration (standard deviation) of substance use/abuse of participants in prison and treatment 
settings. No significant difference was observed in experience of methamphetamine and alcohol abuse 
in their lifetime between inmates and patients. Inmates had more frequently experienced inhalant abuse 
and had less frequently experienced cannabis and methylenedioxymethamphetamine (MDMA) abuse 
than  patients.  Additionally,  inmates  had  a  significantly  shorter  duration  of  methamphetamine  and 
MDMA abuse and a significantly longer duration of alcohol use than patients. Most inmates abused Int. J. Environ. Res. Public Health 2009, 6                 
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methamphetamine  by  injection  (80.8%),  whereas  a  minority  of  patients  used  the  injection  route 
(41.8%). No participants in either group reported cocaine or opiate abuse. 
 
Table 4. Lifetime prevalence of substance use/abuse lasting more than 1 year. 
 
Substance  Inmates (n = 52)  Patients (n = 55)  p values 
Methamphetamine abuse, n (%)  50 (96.2)  52 (94.5)  n.s. 
Duration (years), M (SD)  4.8 (0.63)  8.2 (0.91)  p = 0.001** 
Drug use by injection, n (%)  42 (80.8)  23 (41.8)  p < 0.001*** 
Alcohol use, n (%)  40 (76.9)  41 (74.5)  n.s. 
Duration (years), M (SD)  17.6 (1.39)  15.3 (1.48)  p = 0.0116* 
Cannabis abuse, n (%)  6 (11.5)  23 (41.8)  p < 0.001*** 
Duration (years), M (SD)  6.5 (3.55)  7.0 (1.28)  n.s. 
Methylenedioxymethamphetamine 
abuse, n (%) 
0 (0)  6 (10.9)  p = 0.014* 
Duration (years), M (SD)  0 (0)  2.3 (0.56)  p = 0.015* 
Inhalant abuse, n (%)  32 (61.5)  18 (32.7)  p = 0.003** 
Duration (years), M (SD)  4.1 (0.56)  3.6 (0.65)  n.s. 
n, number of participants; M, mean; SD, standard deviation; n.s., not significant 
Note:  The  Mann-Whitney  Wilcoxon  test  was  used  for  the  statistical  comparison  with 
continuous values. The 
2 test was used for the other categories. 
*p < 0.05, **p < 0.01, ***p < 0.001 
 
3.4. Psychiatric Symptoms 
 
The number and percentage of participants who reported psychiatric symptoms in their lifetime are 
shown  in  Table  5.  The  inmates  experienced  less  major  depression,  anxiety  and  tension,  and 
hallucinations  in  their  lifetime  than  patients.  Additionally,  no  significant  associations  were  found 
between the duration of methamphetamine abuse and these psychiatric symptoms using Spearman’s 
rank  correlation  coefficient  analysis  in  both  groups  (rs  =  −0.006–0.186,  n.s.).  Moreover,  inmates 
received  less  prescribed  medication  in  their  lifetime  than  patients.  Although  these  psychiatric 
symptoms were not common among inmates, the lifetime prevalence of suicidal behavior and trouble 
controlling violence was not significantly lower than in patients. 
 
Table 5. Lifetime prevalence of psychiatric symptoms. 
 
Symptoms 
Inmates (n = 
52) 
n (%) 
Patients (n = 
55) 
n (%) 
p values 
Serious depression (a)  9 (17.3)  24 (43.6)  p = 0.003** 
Serious anxiety or tension (a)  14 (26.9)  25 (45.5)  p = 0.047* 
Hallucinations (a)  3 (5.8)  22 (40.0)  p < 0.001*** Int. J. Environ. Res. Public Health 2009, 6                 
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Trouble understanding, concentrating, or remembering 
(a)  18 (34.6)  18 (32.7)  n.s. 
Trouble controlling violent behavior (b)  20 (38.5)  28 (50.9)  n.s. 
Serious suicidal thoughts (b)  22 (42.3)  29 (52.7)  n.s. 
Suicide attempts (b)  13 (25)  18 (32.7)  n.s. 
Prescribed medication (b)  16 (30.8)  40 (72.7)  p < 0.001*** 
n, number of participants; n.s., not significant 
Note: According to the ASI counting rule, (a) counts only long-lasting symptoms lasting more than 
three months, and (b) counts symptoms that do not last long. The 
2 test was used for statistical 
comparisons. 
*p < 0.05, **p < 0.01, ***p < 0.001 
 
3.5. Variables Related to Drug Abuse Severity 
 
Similarities and differences were observed between the two groups in correlations between the drug 
use CS and some of the other variables. In both groups, the psychiatric status CS (inmates: r = 0.410,  
p  <  0.05;  patients:  r  =  0.283,  p  <  0.05)  and  the  number  of  days  that  participants  experienced 
psychological and emotional problems in the past 30 days (inmates: r = 0.374, p < 0.05; patients:  
r = 0.274, p < 0.05) were significantly and positively correlated with the drug use CS. 
For inmates, the legal status CS (r = 0.328, p < 0.05), days of alcohol problems in the past 30 days 
(r = 0.309, p < 0.05), and subjective feelings of trouble with alcohol problems in the past 30 days  
(r = 0.283, p < 0.05) were significantly and positively correlated with the drug use CS. Additionally, 
the number of close friends (r = −0.276, p < 0.05) and serious problems with their children in the past 
30 days (r = -0.366, p < 0.05) were significantly and negatively correlated with the drug use CS. 
For  patients,  the  employment/support  status  CS  (r  =  0.281,  p  <  0.05),  treatment  for  any 
psychological and emotional problems in a hospital (r = 0.352, p < 0.05), and serious depression in the 
past 30 days (r = 0.383, p < 0.01) were significantly and positively correlated with the drug use CS. 
 
4. Discussion 
 
4.1. Characteristics of Methamphetamine Abusers 
 
In the present study, significant differences were found in the backgrounds and characteristics of 
Stimulant Control Law inmates and participants from treatments settings. The CSs of inmates were 
higher for drug use and legal status and lower for employment/support and psychiatric symptoms than 
patients. A relatively high CS for drug status in the inmates would be attributable to their use of illegal 
drugs in the 30 days before arrest. Interestingly, inmates abused more frequently and spent more money 
on both methamphetamine and alcohol than patients. Significant correlations were observed between 
some items related to alcohol problems and the drug use CS in inmates. These results are consistent 
with the results of Russell et al. [22], indicating that a history of alcohol use is one of the risk factors Int. J. Environ. Res. Public Health 2009, 6                 
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for methamphetamine use. For Japanese inmates, methamphetamine abuse may have some association 
with problematic alcohol drinking. 
The inmates tended to have a better employment status than patients. Most of the inmates had 
regular jobs, received wages, and did not receive financial support. That is, they lived a relatively 
financially independent life compared with patients, although many of them received a substantial 
amount of money illegally. Additionally, the inmates tended not to experience psychotic symptoms, 
such as hallucinations, and not to access medical services for their addictive problems. Many patients 
received treatment for the distress associated with psychotic symptoms rather than for the drug abuse 
itself [23]. These results indicate that inmates abused drugs within a range before their arrest, but their 
psychiatric symptoms were apparently not as severe as those among patients. 
Problems appeared to exist in the inmates’ environments while they were young. Many of them had 
less education and a history of juvenile delinquency. These results are consistent with the results of 
Miura et al. [7] in which the number of admissions to a juvenile detention home significantly predicted 
methamphetamine use during adolescence. Moreover, a history of inhalant abuse was found in more 
than half of the inmates. Inhalant abuse, such as paint thinner abuse, was found to be a significant 
problem leading to methamphetamine abuse among young Japanese [2]. Our results, combined with 
these previous results, suggest that a troubled childhood may lead to illegal drug use in adulthood. 
Methamphetamine-induced psychosis  is  reported  frequently in Japanese patients  diagnosed with 
methamphetamine  dependence  [6].  Additionally,  Wada  and  Fukui  [24]  reported  that  five  years of 
methamphetamine use is considered a turning point in terms of the occurrence of psychotic symptoms, 
suggesting that a shorter duration of methamphetamine abuse in inmates may be related to less frequent 
psychosis. However, no significant association was found between the duration of methamphetamine 
abuse  and  lifetime  experience  of  psychosis  in  the  inmates  and  patients  in  the  present  study. 
Interestingly,  inmates  reported  fewer  psychotic  symptoms,  such  as  hallucinations,  than  patients, 
although no significant differences were found in age between the two groups. This result may reflect 
the fact that inmates with acute psychosis were excluded from the study. Nonetheless, the present 
results suggest that inmates and patients may have different backgrounds contributing to vulnerability 
to methamphetamine-induced psychosis. Further studies with more inmate and patient samples using 
multivariate  statistical  analysis  will  be  needed  to  reveal  the  factors  leading  to  vulnerability  to 
methamphetamine-induced psychosis in methamphetamine dependence/abuse. 
With regard to route of methamphetamine administration, intravenous injection was used by most of 
the inmates, whereas a minority of patients used this route. These results are consistent with the results 
of Matsumoto et al. [6] in which methamphetamine-injecting subjects had more extensive criminal 
records  than  smoking  subjects.  Matsumoto  et  al.  investigated  outpatients  and  reported  significant 
differences  in  life  circumstances  between  injecting  and  smoking  abusers,  and  injecting  abusers 
appeared  to  have greater antisocial  tendencies than smoking abusers.  Moreover, Matsumoto  et  al. 
reported that although methamphetamine abusers often claimed that smoking is safer than injection, no 
significant differences were found in the overall occurrence of psychotic symptoms between injection 
and smoking. Our results consistently showed that the injection route, which was used by most of the 
inmates, might not be a factor causing critical psychotic problems. Int. J. Environ. Res. Public Health 2009, 6                 
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The inmates were less frequently admitted to treatment facilities, possibly because of their less 
frequent  episodes  of  psychosis.  The  inmates  also  expressed  their  psychological  problems  not  as 
depression  or  anxiety,  but  rather  as  uncontrollable  violence,  suicide  attempts,  and  interpersonal 
relationship  problems  with  their  families  and  sexual  partners.  These  results  suggest  that  inmates 
expressed their psychological problems outwardly rather than viewed their psychological problems as 
an inner conflict. For inmates, the correct perceptions of their problems may be especially important 
for  treatment  [25].  Treatment  programs  should  be  implemented  not  only  for  patients  but  also  
for inmates. 
 
4.2. Strengths and Limitations of the Study 
 
The present study provides basic statistical information about Japanese methamphetamine abusers 
in correctional settings measured by the ASI compared with abusers in treatment settings. Although 
Wada  et  al.  [3]  reported  that  most  Japanese  methamphetamine  abusers  belonged  to  correctional 
settings rather than treatment settings, characteristics of methamphetamine abusers in prisons have not 
been as well studied as those of abusers in hospital settings. The results of this study indicate many 
differences  in  the  quantity  and  quality  of  methamphetamine  abuse  between  inmates  and  patients. 
Additionally, the present study showed that the ASI could be an effective tool not only for patients but 
also for inmates to grasp the severity of their problems in multiple areas. The accumulation of data on 
incarcerated methamphetamine abusers in Japan might extend the use of the ASI as an interview tool. 
One possible limitation of the present study was the sampling procedure. The participants were not 
recruited  randomly  but  were  limited  to  inmates  who  gave  informed  consent  and  whose  doctors 
recognized their ability to be interviewed. Therefore, the data of this study were not obtained from 
methamphetamine  abusers  in  prison  as  a  whole,  but  rather  only  from  cooperative  inmates  with  a 
relatively  low  severity  of  methamphetamine  dependence.  Additionally,  Shizuoka  prison  especially 
treated offenders who were imprisoned for the first time, and offenders mainly came from Tokyo or 
Shizuoka  prefectures.  Consequently,  the  results  of  this  study  reflect  only  a  portion  of  the 
methamphetamine  abuse  prisoner  population.  Inmates  and patients  were  also  recruited at  different 
time-points, although the situation regarding methamphetamine use in Japan minimally changed from 
2002 to 2007. Moreover, the large number of statistical tests performed in the present study might 
make some results significant by chance. Another limitation was the relatively low sample size. A 
subsequent  study  with  more  subjects  from  other  correctional  facilities  and  multivariate  statistical 
analysis will be necessary to confirm our conclusions. 
In the future, the wide use of the ASI for methamphetamine abusers in correctional facilities will 
enable systematic collection of basic information from these subjects which may aid in more effective 
intervention. The ASI may be useful for selecting adequate treatment and re-education programs for 
inmates.  Additionally,  utilization  of  the  ASI  as  a  common  tool  among  facilities  that  treat 
methamphetamine abusers, such as hospitals (or other treatment facilities), legal facilities (e.g., prisons 
or probation offices), and research institutes, may contribute to more effective treatment and research. 
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5. Conclusions 
 
These findings suggest that Japanese methamphetamine abusers in correctional settings have many 
characteristics  and  environmental  backgrounds  that  are  different  from  abusers  in  medical  settings. 
Methamphetamine abusers in correctional settings may need to have their specific problems assessed, 
including trouble with mental health and access to support facilities. 
 
Acknowledgements 
 
We are grateful to the volunteers for their participation in this study. We are also grateful to Hideko 
Yamamoto,  Yukio  Takamatsu,  Yoko  Ishibashi,  Fumiyuki  Chin,  and  Michael  Arends  for  fruitful 
discussions and proofreading. This work was supported by grants from the Ministry of Education, 
Culture, Sports, Science and Technology of Japan (government department; 17025054), the Ministry of 
Health, Labour and Welfare of Japan (government department; H19-Iyaku-023, H17-Pharmaco-001), 
the  Japan  Society  for  the  Promotion  of  Science  (quasi-governmental  organization;  17730421, 
17591238), and the Mitsubishi Foundation for Social Welfare Activities. 
 
References 
 
1.  United Nations Office on Drugs and Crime. Amphetamine-type stimulants in East Asia and the 
Pacific.  Asia  and  Pacific  Amphetamine-Type  Stimulants  Information  Center,  2004.  Available 
online: http://www.apaic.org/lb/cd.009.htm (accessed August 14, 2009). 
2.  Wada, K.; Kikuchi, A.; Nakano, R.; Ozaki, S. Current situation on drug abuse in Japan: using a 
general population survey and a junior high school student’s survey. Nihon Arukoru Yakubutsu 
Igakkai Zasshi 2004, 39, 28-34. 
3.  Wada,  K.;  Ozaki,  S.;  Kondo,  A.  Current  situation  of  and  the  political  measures  for  drug 
abuse/dependence. Nihon Arukoru Yakubutsu Igakkai Zasshi 2008, 43, 120-131. 
4.  Ikeda, K.; Yamamoto, H.; Takamatsu, Y.; Haraguchi, A.; Umeno, M.; Senoo, E. New approaches 
toward treatment of methamphetamine dependence. Seishin Igaku 2004, 46, 57-72. 
5.  Ministry  of  Justice  Research  and  Training  Institute.  White  Paper  on  Crime  in  Japan  2003. 
Ministry of Finance Printing Bureau: Tokyo, Japan, 2004; pp. 305-314. 
6.  Matsumoto, T.; Kamijo, A.; Miyakawa, T.; Endo, K.; Yabana, T.; Kishimoto, H.; Okudaira, K.; 
Iseki,  E.;  Sakai,  T.;  Kosaka,  K.  Methamphetamine  in  Japan:  the  consequences  of 
methamphetamine abuse as a function of route of administration. Addiction 2002, 97, 809-817. 
7.  Miura, H.; Fujiki, M.; Shibata, A.; Ishikawa, K. Prevalence and profile of methamphetamine users 
in adolescents at a juvenile classification home. Psychiatry Clin. Neurosci. 2006, 60, 352-357. 
8.  Matsumoto, T.; Okada, T.; Chiba, Y.; Ando, Y.; Yoshikawa, K.; Wada, K. Association between 
substance abuse problems and antisocial tendencies in male juvenile delinquents: a study using the 
Psychopathy Checklist, Youth Version. Nihon Arukoru Yakubutsu Igakkai Zasshi 2006, 41, 59-71. Int. J. Environ. Res. Public Health 2009, 6                 
 
 
3068 
9.  Matsumoto, T.; Yamaguchi, A.; Asami, T.; Kamijo, A.; Iseki, E.; Hirayasu, Y.; Wada, K. Drug 
preferences  in  illicit  drug  abusers  with  a childhood tendency of attention deficit/hyperactivity 
disorder: a study using the Wender Utah Rating Scale in  a Japanese prison.  Psychiatry Clin. 
Neurosci. 2005, 59, 311-318. 
10.  McLellan,  A.T.;  Kushner,  H.;  Metzger,  D.;  Peters,  R.;  Smith,  I.;  Grissom,  G.;  Pettinati,  H.; 
Argeriou, M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 1992, 9, 
199-213. 
11.  Springer,  D.W.;  McNeece,  C.A.;  Arnold,  E.M.  Substance  Abuse  Treatment  for  Criminal 
Offenders:  An  Evidence-Based  Guide  for  Practitioners;  American  Psychological  Association: 
Washington, DC, USA, 2003. 
12.  Vandevelde, S.; Broekaert, E.; Schuyten, G.; Van Hove, G. Intellectual abilities and motivation 
toward substance abuse treatment in drug involved offenders: a pilot study in the Belgian criminal 
justice system. Int. J. Offender Ther. Comp. Criminol. 2005, 49, 277-297. 
13.  Peters, R.H.; Greenbaum, P.E.; Steinberg, M.L.; Carter, C.R.; Ortiz, M.M.; Fry, B.C.; Valle, S.K. 
Effectiveness of screening instruments in detecting substance use disorders among prisoners. J. 
Subst. Abuse Treat. 2002, 18, 349-358. 
14.  Kravitz, H.M.; Cavanaugh, J.L., Jr.; Rigsbee, S.S. A cross-sectional study of psychosocial and 
criminal factors associated with arrest in mentally ill female detainees. J. Am. Acad. Psychiatry 
Law. 2002, 30, 380-390. 
15.  Wunsch,  M.J.;  Nakamoto,  K.;  Goswami,  A.;  Schnoll,  S.H.  Prescription  drug  abuse  among 
prisoners in rural Southwestern Virginia. J. Addict. Dis. 2007, 26, 15-22. 
16.  Haas,  A.L.;  Peters,  R.H.  Development  of  substance  abuse  problems  among  drug-involved 
offenders: evidence for the telescoping effect. J. Subst. Abuse 2000, 12, 241-253. 
17.  Gordon,  M.S.;  Kinlock,  T.W.;  Schwarts,  R.P.;  O’Grady,  K.E.  A  randomized  clinical  trial  of 
methadone  maintenance  for  prisoners:  finding at  6 months  post-release.  Addiction 2008,  103, 
1333-1342. 
18.   Hiller, M.L.; Narevic, E.;  Webster, J.M.;  Rosen, P.; Staton, M.;  Leukefeld,  C.; Garrity, T.F.; 
Kayo, R. Problem severity and motivation for treatment in incarcerated substance abusers. Subst. 
Use Misuse 2009, 44, 28-41. 
19.   Senoo, E.; Ogai, Y.; Haraguchi, A.; Kondo, A.; Ishibashi, Y.; Umeno, M.; Kikumoto, H.; Hori, T.; 
Komiyama, T.; Kato, R.; Aso, K.; Asukai, N.; Wada, K.; Saitoh, S.; Ikeda, K. Reliability and 
validity  of  the  Japanese  version  of  the  Addiction  Severity  Index  (ASI-J).  Nihon  Arukoru 
Yakubutsu Igakkai Zasshi 2006, 41, 368-379. 
20.  American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. 
American Psychiatric Press: Washington, DC, USA, 1994. 
21.  Delucchi,  K.L.;  Bostrom,  A.  Methods  for  analysis  of  skewed  data  distributions  in  psychiatric 
clinical studies: working with many zero values. Am. J. Psychiatry 2004, 161, 1159-1168. 
22.   Russell, K.; Dryden, D.M.; Liang, Y.; Friesen, C.; O’Gorman, K.; Durec, T.; Wild, T.C.; Klassen, 
T.P. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatr. 2008,  
8, 48. Int. J. Environ. Res. Public Health 2009, 6                 
 
 
3069 
23.  Ikeda, K.; Yamamoto, H.; Takamatsu, Y.; Haraguchi, A.; Umeno, M.; Senoo, E. New approaches 
toward treatment of methamphetamine dependence. Seishin Igaku 2004, 46, 57-72. 
24.  Wada,  K.;  Fukui,  S.  Relationship  between  years  of  methamphetamine  use  and  symptoms  of 
methamphetamine psychosis. Arukoru Kenkyuto Yakubutsu Ison 1990, 25, 143-158. 
25.  Ferrari,  J.R.;  Groh,  D.R.;  Rulka,  G.;  Jason,  L.A.;  Davis,  M.I.  Coming  to  terms  with  reality: 
predictors of self-deception within substance abuse recovery. Addict. Disord. Their Treat. 2008, 7, 
210-218. 
 
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This  article  is  an  open-access  article  distributed  under  the  terms  and  conditions  of  the  Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 